Pharmacological characterization of the first in class clinical candidate PF‐05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal...

per Kong, J, Chuddy, J, Stock, I A, Loria, P M, Straub, S V, Vage, C, Cameron, K O, Bhattacharya, S K, Lapham, K, McClure, K F, Zhang, Y, Jackson, V M
Publicat a Br J Pharmacol (2016)